Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study. [electronic resource]
Producer: 20140429Description: 143-7 p. digitalISSN:- 1220-4749
- Adult
- Aged
- Anti-Infective Agents -- therapeutic use
- Bacterial Infections -- complications
- Blind Loop Syndrome -- drug therapy
- Breath Tests -- methods
- Female
- Hospitals, University
- Humans
- Intestine, Small -- drug effects
- Irritable Bowel Syndrome -- drug therapy
- Male
- Middle Aged
- Pilot Projects
- Rifamycins -- therapeutic use
- Rifaximin
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.